• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

London Capital Group Holdings PLC

  • ID: 647689
  • April 2015
  • 38 Pages
  • Wright Investors Service

A textual analysis of the financial results for London Capital Group Holdings PLC compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the company, including contact information, senior officers and Wright Quality Rating analyses is also provided.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio tables (Accounting, Asset Utilization, Employee Efficiency, Fixed Charges Coverage, Leverage Analysis, Liquidity Analysis, Per-share Data and Profitability Analysis) and proprietary Wright Quality Rating analyses tables. The Wright Quality Rating, a measure of corporate risk, examines the liquidity of the stock, financial strength, profitability and corporate growth characteristics of London Capital Group Holdings PLC. There is a textual review of the financial results of London Capital Group Holdings PLC versus Panmure Gordon & Company PLC, Share Plc and Cenkos Securities Plc. The comparative analysis of these companies READ MORE >

Note: Product cover images may vary from those shown

Company Fundamentals
- Company Profile
- Comparative Business Analysis
- Summary Analysis per Share
- Sales Analysis
- Price Analysis
- Earnings and Dividends Analysis

Financial Statement Analyses
- Balance Sheet - Common Size
- Balance Sheet - Year-Year Percent Change
- Balance Sheet - Five-Year Averages
- Income Statement - Common Size
- Income Statement - Year-Year Percent Change
- Income Statement - Five-Year Averages
- Sources of Capital

Financial Ratio Analyses
- Accounting Ratios
- Asset Utilization
- Employee Efficiency
- Fixed Charges Coverage
- Leverage Analysis
- Liquidity Analysis
- Per-Share Data
- Profitability Analysis

Wright Quality Rating Analyses
- Investment Acceptance
- Financial Strength
- Profitability and Stability
- Corporate Growth

Note: Product cover images may vary from those shown

United Kingdom

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

  • Next PLC - Product Thumbnail Image

    Next PLC

    • Language: English
    • 54 Pages
    • Published: April 2015
    FROM
  • London Finance & Investment Group PLC - Product Thumbnail Image

    London Finance & Investment Group PLC

    • Language: English
    • 35 Pages
    • Published: May 2015
    FROM
  • Numis Corporation PLC - Product Thumbnail Image

    Numis Corporation PLC

    • Language: English
    • 34 Pages
    • Published: March 2015
    FROM
  • Panmure Gordon & Company PLC - Product Thumbnail Image

    Panmure Gordon & Company PLC

    • Language: English
    • 38 Pages
    • Published: March 2015
    FROM
  • London Stock Exchange Group Plc - Product Thumbnail Image

    London Stock Exchange Group Plc

    • Language: English
    • 36 Pages
    • Published: March 2015
    FROM
  • London Security Plc - Product Thumbnail Image

    London Security Plc

    • Language: English
    • 55 Pages
    • Published: April 2015
    FROM
  • City of London Group PLC - Product Thumbnail Image

    City of London Group PLC

    • Language: English
    • 38 Pages
    • Published: April 2015
    FROM
  • Bourse Direct - Product Thumbnail Image

    Bourse Direct

    • Language: English
    • 37 Pages
    • Published: April 2015
    FROM
  • Derwent London Plc - Product Thumbnail Image

    Derwent London Plc

    • Language: English
    • 38 Pages
    • Published: April 2015
    FROM
  • Telefonica SA - Product Thumbnail Image

    Telefonica SA

    • Language: English
    • 57 Pages
    • Published: April 2015
    FROM

Our Clients

Fluidigm Corporation Apple, Inc. CEVA Santé Animale Abbott Laboratories Ltd. Merck Group Allergan Inc. Pfizer, Inc.